July 19 (Reuters) - Zhejiang Hisun Pharmaceutical Co., Ltd. : * Says it signs $3 million technology transfer agreement with Nascent Biotech, Inc, to get exclusive right for Pritumumab, a targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback